The incidence of PrAKI among all AKI admissions in our institute is 0.76%. 583 PrAKI patients were admitted during the study period. 7.2% patients were given peritoneal dialysis. 38.4% patients were managed conservatively. 54.3% of patients underwent HD. All patients who underwent PD were postpartum
In the present study, the majority of subjects (69.0%) were below 25 years of age, while 31.0% were above 25 years. With respect to parity, 52.4% were primigravida and 47.6% were multigravida. Most subjects were in the post-partum period (66.7%), whereas 33.3% were in the third trimester. Notably, 52.4% of subjects had preeclampsia, while 47.6% did not. The majority of deliveries were by lower segment cesarean section (LSCS) at 92.9%, with only 7.1% delivering vaginally. Intrauterine death (IUD) was reported in 35.7% of cases, with 64.3% showing no IUD. Among the reasons for referral, 52.4% were due to combined renal dysfunction and oliguria, 26.2% for renal dysfunction alone, 11.9% for oliguria, and 9.5% for anuria.
In this study, PD was initiated within 3 days for half of the subjects (50.0%). For 42.9% of the subjects, PD was started at 3 to 7 days, while only 7.1% had PD initiation beyond 7 days.
Renal dysfunction was the most common indication for initiating PD, observed in 40.5% of the cases. Oliguria accounted for 33.3%, followed by fluid overload in 16.7% and anuria in 9.5% of the subjects. This suggests that the majority of cases had renal impairment or fluid imbalance as the primary indication.
Full recovery ( serum creatinine less than 1 mg/dl) was documented in 28.5% of the subjects, partial recovery ( deranged RFT but not requiring dialysis) was observed in 57.1% subjects while 14.2% were progressed to CKD -5D.
61.9% of the babies were alive, while intrauterine death (IUD) occurred in 35.7% of cases. Neonatal death was noted in 2.4% of the cases.
26.2% of the subjects did not experience any complications related to peritoneal dialysis (PD). However, PD leak was the most common complication, observed in 23.8% of the subjects. Exit site infection was reported in 14.3%, followed by bleeding in 11.9%, PD block in 9.5%, and peritonitis in 4.8% of cases. Less common complications included infection, high blood sugars, catheter block, and sepsis—each accounting for 2.4%.
In this study, comparison of biochemical parameters revealed that SGOT and SGPT levels were significantly higher in non-survivors (117.89 ± 13.6 IU/L and 126.46 ± 11.7 IU/L, respectively) compared to survivors (42.84 ± 7.8 IU/L and 47.43 ± 7.4 IU/L, respectively), with p-values of 0.02 and 0.021, indicating a statistically significant difference. Serum creatinine before PD was also significantly higher among non survivors (4.32 ± 2.13 mg/dL) than in survivors (2.75 ± 1.29 mg/dL), with a p-value of 0.005. Day of initiation of peritoneal dialysis postpartum is low in survivors compared to non survivors, signifies that early initiation improved outcomes of survival with a significant p. value of 0.036*. Other parameters such as Hb, WBC, platelet count, ALP, TSB, blood urea, did not show statistically significant differences between the groups (p > 0.05), although notable trends were observed.
Demographic and clinical variables showed no statistically significant association between survival outcomes and age, parity, gestational period, presence of hypertension, preeclampsia, mode of delivery, or referral source (p > 0.05 for all). Though all three vaginal deliveries resulted in non-survival, and all hypertensive subjects died, these differences did not reach statistical significance, possibly due to small subgroup sizes.
Analysis of outcome-related factors revealed no statistically significant association between child condition and maternal survival (p = 0.575), though 71.4% of survivors had live births compared to 57.1% of non-survivors. The type of dialysis showed a trend toward significance (p = 0.05), with PD alone being more common among non-survivors (89.3%) than survivors (64.3%), while PD+HD was more frequently used in survivors (35.7%) than non-survivors (7.1%), signifying combination of PD+ HD improved survival outcomes.